AUS
NZ
UK
CA
USA
IND
Health
Pfizer (NYSE:PFE) Gains Focus As Healthcare Holds Firm
June 25, 2026 03:40 AM AEST| By Anmol KhazanchiHealthcare remains steady as market sentiment shifts, with pharmaceutical demand, regulatory focus, and drug-pricing debate shaping attention around major names in the sector.
UnitedHealth (NYSE:UNH) Stays Steady In Healthcare
June 25, 2026 03:38 AM AEST| By Anmol KhazanchiUnitedHealth stayed in focus as healthcare showed resilience during technology weakness and market rotation.
Johnson & Johnson (NYSE:JNJ) Rises As Tech Slips
June 25, 2026 03:11 AM AEST| By Anmol KhazanchiHealthcare stayed firm during technology weakness, with diversified pharma and medical device exposure helping one major U.S. healthcare name draw renewed market attention.
Novo Nordisk (NYSE:NVO) Valuation Debate Deepens
June 25, 2026 01:25 AM AEST| By Anmol KhazanchiNovo Nordisk remains under market focus as valuation models, pharma demand, cash flow strength, earnings metrics, and sector risks shape the latest discussion around the stock.
Thermo Fisher (NYSE:TMO) Draws Attention With Expanding AI Strategy
June 25, 2026 01:06 AM AEST| By Anmol KhazanchiArtificial intelligence initiatives, healthcare innovation, and integrated research solutions continue shaping attention around a leading life sciences company operating across multiple areas of scientific development.
Can Cencora (NYSE:COR) Turn New Initiatives Into Momentum?
June 25, 2026 12:43 AM AEST| By Anmol KhazanchiNew technology initiatives and leadership changes have placed Cencora in focus as stakeholders monitor operational execution and future strategic direction.
Eli Lilly (NYSE:LLY): What Does The Abbisko Deal Mean?
June 25, 2026 12:29 AM AEST| By Anmol KhazanchiEli Lilly's Abbisko partnership expands research capabilities and adds new opportunities to its future drug development pipeline.
Why Is (NYSE:DHR) Drawing S&P 500 Focus Following FDA AI Monitoring Approval?
June 24, 2026 04:54 PM AEST| By Anmol KhazanchiDanaher (NYSE:DHR) within S&P 500 integrates AI monitoring through Masimo FDA clearance, advancing hospital respiratory detection systems and connected clinical data infrastructure.
Why Is (NYSE:WST) Drawing Attention as S&P 500 GLP-1 Demand Grows?
June 24, 2026 03:41 PM AEST| By Anmol KhazanchiWest Pharmaceutical Services supplies injectable containment and delivery technologies. S&P 500 healthcare activity, biologics manufacturing, and GLP-1 demand continue influencing operations globally.
UnitedHealth Group (NYSE:UNH) Draws Healthcare Market Focus
June 24, 2026 05:14 AM AEST| By Anmol KhazanchiUnitedHealth Group returns to focus as managed-care names rebound and Optum remains central.
Pfizer (NYSE:PFE) Enters A Bigger Healthcare Moment
June 24, 2026 05:09 AM AEST| By Anmol KhazanchiHealthcare attention around Pfizer reflects its expanding obesity program, oncology work, vaccine base, and broad medicine pipeline as pharmaceutical innovation remains central to sector discussion.
Eli Lilly (NYSE:LLY) Fuels Weight-Care Buzz
June 24, 2026 05:04 AM AEST| By Anmol KhazanchiEli Lilly remains central to weight-care medicine as tirzepatide brands, oral treatment work, supply expansion, and metabolic-health research keep the company prominent in healthcare.
How Centene (NYSE:CNC) Is Strengthening Its Strategy Through Governance and Efficiency
June 24, 2026 04:54 AM AEST| By Anmol KhazanchiDiscover how Centene (NYSE:CNC) is refining governance, strengthening operational discipline, and navigating healthcare market changes to support sustainable growth and long-term business performance.
Can Pfizer (NYSE:PFE) Clear Its Latest Oncology Hurdle?
June 24, 2026 02:40 AM AEST| By Anmol KhazanchiPfizer's lung cancer trial miss keeps focus on subgroup hope and oncology execution.
Abbott Laboratories (NYSE:ABT): Is Market Too Harsh?
June 24, 2026 02:25 AM AEST| By Anmol KhazanchiAbbott's market slide has renewed focus on valuation, cash flow strength, and healthcare growth.
Merck (NYSE:MRK) Gains Attention After Key Drug Advances
June 24, 2026 01:54 AM AEST| By Anmol KhazanchiStrong pipeline developments, regulatory approvals, and advancing clinical programs have reinforced attention on pharmaceutical innovation, portfolio expansion, and long-term healthcare industry growth.
Why Are Hospital Chain Stocks Drawing Attention [S&P 500]
June 23, 2026 02:34 PM AEST| By Anmol KhazanchiHospital operators remain in focus as healthcare demand, technology modernization, and healthcare infrastructure discussions continue shaping sector activity.
Pfizer (NYSE:PFE): A Healthcare Shift Worth Watching
June 23, 2026 04:22 AM AEST| By Anmol KhazanchiPfizer remains in focus as expanded hemophilia approval strengthens rare disease visibility while organizational transition adds fresh attention to its broader pharmaceutical and healthcare story.
UnitedHealth Group (NYSE:UNH): Comeback In Focus?
June 23, 2026 04:19 AM AEST| By Anmol KhazanchiUnitedHealth Group drew renewed attention as a comeback narrative built around the managed care company, with the broader healthcare sector gaining ground amid a rotation toward defensive areas of the market.
Can Eli Lilly (NYSE:LLY) GLP-1 Pill Reshape The Conversation?
June 23, 2026 04:11 AM AEST| By Anmol KhazanchiEli Lilly remains central to healthcare discussion as its oral GLP-One pill advances through pivotal trials, adding focus to obesity care, diabetes treatment, and pharmaceutical innovation.
